LENALIDOMIDE (LENALIDOMIDE) — FDA Approval ANDA217281 (NOVUGEN)
LENALIDOMIDE (LENALIDOMIDE) — FDA Approval ANDA217281 (NOVUGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LENALIDOMIDE; Active ingredients: LENALIDOMIDE; Application number: ANDA217281.
| Brand name | LENALIDOMIDE |
|---|---|
| Active ingredients | LENALIDOMIDE |
| Application number | ANDA217281 |
| Sponsor | NOVUGEN |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 6 |
| First approval date | 20240911 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →